GMMMG logo

NHS photos

NHS logo

Recommendations

On this page you will find all our current recommendations, initially sorted by published date. The ‘Recommendations’ and ‘Published’ column headings are active links that will sort the information in ascending or descending order. Please note that all our recommendations are valid unless they are superseded by NICE or national guidance.

If you are a healthcare professional working with the GM region and would like to submit information for a recommendation to be reviewed then please contact the professional secretary to the group.

To view our recommendations sorted by BNF chapter or to view those superseded by NICE or national guidance click the links to the left.

Please note that the new drug recommendations no longer contain a review date as they will be reviewed as and when substantial new evidence that may change the original recommendation becomes available. This will be highlighted through regular horizon scanning activities. All previous review dates on old recommendations are invalid as they will also be reviewed as outlined. In addition if a NICE TA is published then the new drug recommendation will be superseded by the NICE TA – these recommendations will be moved to the archive recommendation section of the website within 90 days of the NICE TA being issued.

display

106 recommendations currently listed 

spacer 

spacer 

spacer 

spacer 

spacer 

 

spacer

RecommendationsA-Z asc 

Published 

Status 

 

pdf document (105 KB)  

Aclidinium for COPD  

Oct 2012 

Final 

 

pdf document (221 KB)  

Aclidinium/ Formoterol (Duaklir ® Genuair ®) inhaler for COPD  

Jan 2015 

Final 

 

pdf document (115 KB)  

Agomelatine for Depression (updated)  

Mar 2014 

Final 

 

pdf document (104 KB)  

Aliskiren for Hypertension  

Dec 2007 

Final 

 

pdf document (134 KB)  

Alprostadil Cream for ED  

Aug 2014 

Final 

 

pdf document (210 KB)  

Anal Irrigation systems for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence  

Nov 2015 

Final 

 

pdf document (91 KB)  

Aripiprazole prolonged release injection (Abilify Maintena®) for the treatment of Schizophrenia  

Apr 2014 

Final 

 

pdf document (136 KB)  

Asenapine for Acute Mania  

Mar 2012 

Final 

 

pdf document (138 KB)  

Avanafil for ED  

Aug 2014 

Final 

 

pdf document (177 KB)  

Benepali® (etanercept) Biosimilar  

Mar 2016 

Final 

 

pdf document (94 KB)  

Bevacizumab in AMD updated  

Nov 2015 

 

 

pdf document (648 KB)  

Blood Glucose Testing Strips Evaluation  

Dec 2017 

Review postponed indefinitely 

 

pdf document (165 KB)  

Brimonidine (Mirvaso®) gel for acne rosacea erythema  

Jun 2014 

Final 

 

pdf document (151 KB)  

Brivaracetam (Briviact®▼) for adjunctive treatment of focal onset seizures.  

May 2016 

Final 

 

pdf document (212 KB)  

Capsaicin patches (Qutenza®) for the treatment of peripheral neuropathic pain in non-diabetic adults  

Nov 2015 

Final 

 

pdf document (108 KB)  

Clopidogrel (STEMI)  

May 2007 

Final 

 

pdf document (177 KB)  

Colchicine for the treatment of pericarditis pain (Unlicensed indication)  

Jul 2016 

Final 

 

pdf document (104 KB)  

Colesevelam for Hypercholesterolaemia  

Mar 2008 

Final 

 

pdf document (63 KB)  

Combodart® for BPH  

Aug 2010 

Final 

 

pdf document (93 KB)  

Cystistat® (sodium hyaluronate) solution for interstitial cystitis  

Jul 2014 

Final 

 

pdf document (217 KB)  

Dapoxetine for PE  

Dec 2013 

Final 

 

pdf document (88 KB)  

Denosumab for the treatment of osteoporosis in men  

Oct 2014 

Final 

 

pdf document (147 KB)  

Duavive® for the treatment of oestrogen deficiency symptoms in postmenopausal women  

Mar 2017 

Final 

 

pdf document (207 KB)  

Dymista® for Severe Allergic Rhinitis  

Jan 2016 

Final 

 

pdf document (135 KB)  

E-Voke® (nicotine) electronic inhaler device  

Jan 2016 

Final 

 

pdf document (60 KB)  

Eflornithine cream for facial hirsuitism  

Jul 2007 

Final 

 

pdf document (142 KB)  

Eplerenone for heart failure  

Jul 2013 

Final 

 

pdf document (160 KB)  

Fast-acting insulin aspart (Fiasp ®▼)  

Jul 2017 

Final 

 

pdf document (102 KB)  

Fentanyl Products for Pain  

Feb 2010 

Final 

 

pdf document (99 KB)  

Fidaxomicin for c.diff Infection  

Jun 2012 

Final 

 

pdf document (168 KB)  

Fluticasone furoate plus vilanterol (Relvar Ellipta®) for COPD.  

Dec 2014 

Final 

 

pdf document (167 KB)  

Fluticasone furoate plus vilanterol (Relvar Ellipta®) for asthma.  

Dec 2014 

Final 

 

pdf document (127 KB)  

Fostair® (beclometasone dipropionate and formoterol fumarate dehydrate) metered dose inhaler for COPD  

Jun 2014 

Final 

 

pdf document (218 KB)  

FreeStyle Libre® Flash Glucose Monitoring System.  

Oct 2017 

Final 

 

pdf document (176 KB)  

Gabapentin or Pregabalin for the treatment of chronic cough (unlicensed indication)  

Jul 2016 

Final 

 

pdf document (161 KB)  

Glycopyrronium for COPD  

Oct 2012 

Final 

 

pdf document (32 KB)  

GMMMG Vitamin D statement  

Sep 2016 

 

 

pdf document (162 KB)  

Grazax for Hayfever  

Jun 2010 

Final 

 

pdf document (176 KB)  

Guanfacine (Intuniv®▼) for the treatment of ADHD in children and adolescents  

Jan 2016 

Final 

 

pdf document (138 KB)  

Histrelin for prostate cancer  

Mar 2011 

Final 

 

pdf document (117 KB)  

HPV Vaccine  

Sep 2007 

Final 

 

pdf document (85 KB)  

Hydrocortisone modified release tablet (Plenadren®) for the treatment of adrenal insufficiency  

Apr 2014 

Final 

 

pdf document (178 KB)  

Idarucizumab (Praxbind®▼) for the reversal of dabigatran anticoagulation  

Mar 2016 

Final 

 

pdf document (141 KB)  

Indacaterol (OnBrez®) for COPD  

Mar 2010 

Final 

 

pdf document (222 KB)  

Indacaterol plus glycopyrronium (Ultibro®) in COPD  

Nov 2013 

Final 

 

pdf document (133 KB)  

Inhaled Loxapine for agitation  

Mar 2013 

Final 

 

pdf document (113 KB)  

Insulin Degludec for Type 1 and 2 DM (updated)  

Jun 2014 

Final 

 

pdf document (282 KB)  

Insulin Glargine Biosimilar  

Sep 2015 

Final 

 

pdf document (266 KB)  

Ivermectin Cream for the treatment of acne rosacea  

Sep 2015 

Final 

 

pdf document (137 KB)  

Lacosamide for partial onset seizures  

Jun 2011 

Final 

 

pdf document (78 KB)  

Lidocaine Plasters for PHN  

Apr 2014 

Final 

 

pdf document (113 KB)  

Linaclotide for IBS-C  

Jan 2013 

Final 

 

pdf document (181 KB)  

Liraglutide for Obesity  

Feb 2018 

Final 

 

pdf document (142 KB)  

Lodotra® for RA  

Feb 2011 

Final 

 

pdf document (82 KB)  

Lurasidone (Latuda®) for treatment of Schizophrenia  

Mar 2014 

Final 

 

pdf document (196 KB)  

Melatonin (Circadin®) in sleep disorders in children  

Feb 2014 

Final 

 

pdf document (140 KB)  

Melatonin for primary insomnia (adults)  

Sep 2008 

Final 

 

pdf document (112 KB)  

Metoject (methotrexate) Injection for RA  

Oct 2008 

Final 

 

pdf document (159 KB)  

Modafinil for CSWSD  

May 2008 

Final 

 

pdf document (89 KB)  

Nabilone for the treatment of chronic non cancer pain (unlicensed indication)  

Dec 2014 

Final 

 

pdf document (96 KB)  

Nalmefene for alcohol dependence  

Nov 2014 

Final 

 

pdf document (94 KB)  

Newer Products [Fluorouracil + salicylic acid (Actikerall®), imiquimod 3.75% (Zyclara®) and ingenol (Picato®)] for the topical treatment of Actinic Keratoses (AK)  

Feb 2014 

Final 

 

pdf document (143 KB)  

Octreotide for treatment of certain gastrointestinal indications  

May 2018 

 

 

pdf document (195 KB)  

Olodaterol (Striverdi ® Respimat ®) inhaler for COPD  

Sep 2014 

Final 

 

pdf document (177 KB)  

Opicapone (Ongentys®▼) for the management of mid to late Parkinson’s Disease  

Sep 2016 

Final 

 

pdf document (775 KB)  

Oraya therapy (IRAY®) for wet AMD  

Dec 2015 

 

 

pdf document (112 KB)  

Paliperidone depot for Schizophrenia (updated)  

Mar 2014 

Final 

 

pdf document (195 KB)  

Perampanel for partial onset seizures  

Oct 2013 

Final 

 

pdf document (137 KB)  

PICO® dressings for difficult to manage wounds  

May 2015 

Final 

 

pdf document (109 KB)  

Pollinex Quattro for treatment of rhinitis and conjunctivitis  

Jul 2012 

Final 

 

pdf document (102 KB)  

Probiotics (updated)  

Apr 2013 

 

 

pdf document (103 KB)  

Qlaira® (COC)  

Jul 2009 

Final 

 

pdf document (139 KB)  

Racecadotril for acute diarrhoea  

Dec 2012 

Final 

 

pdf document (114 KB)  

Rifaximin for travellers diarrhoea  

Jun 2012 

Final 

 

pdf document (63 KB)  

Risperidone (Paediatric) for learning disabilities or autism-spectrum disorders  

Jul 2008 

Final 

 

pdf document (346 KB)  

Rituximab for Treatment of Refractory Primary Idiopathic Immune Cytopenias  

May 2018 

 

 

pdf document (62 KB)  

Rivastigmine for Dementia with Lewy Bodies  

Feb 2010 

Final 

 

pdf document (113 KB)  

Rivastigmine for Parkinson's disease dementia  

Dec 2007 

Final 

 

pdf document (178 KB)  

Rotigotine for parkinsons disease  

Aug 2007 

Final 

 

pdf document (138 KB)  

Rufinamide for LGS  

Jun 2010 

Final 

 

pdf document (179 KB)  

Safinamide (Xadago®) for the management of mid to late Parkinson’s Disease  

Jul 2016 

Final 

 

pdf document (90 KB)  

Sativex® for the treatment of non-MS neuropathic pain (unlicensed indication)  

Dec 2014 

Final 

 

pdf document (88 KB)  

Simbrinza® (Brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) combination eye drops for glaucoma  

Apr 2015 

Final 

 

pdf document (166 KB)  

SMART-MART Regimen in asthma  

Nov 2013 

Final 

 

pdf document (162 KB)  

Sodium oxybate (Xyrem®) in the management of narcolepsy with cataplexy in adult patients.  

Jul 2017 

Final 

 

pdf document (71 KB)  

Sodium Oxybate for narcolepsy  

Apr 2010 

Final 

 

pdf document (178 KB)  

Sufentanil sublingual tablet system (Zalviso®) for acute post-operative pain  

Mar 2016 

Final 

 

pdf document (278 KB)  

Tapentadol for pain  

Nov 2015 

Final 

 

pdf document (141 KB)  

Targinact for pain  

Sep 2009 

Final 

 

pdf document (202 KB)  

Tempe® (lidocaine-prilocaine) for PE Spray  

Dec 2013 

Final 

 

 

The GMMMG recommendation on Esmya® has been temporarily suspended pending the outcome of the MHRA safety review [no link]  

May 2016 

 

 

 

The GMMMG recommendation on Esmya® has been temporarily suspended pending the outcome of the MHRA safety review [no link]  

Dec 2013 

 

 

pdf document (98 KB)  

Tiotropium (Spiriva® Respimat®) Inhaler for adults with asthma  

Feb 2015 

Final 

 

pdf document (121 KB)  

Tiotropium/Olodaterol (Spiolto® Respimat®) combination inhaler for COPD  

Jul 2015 

Final 

 

pdf document (117 KB)  

Topical Gabapentin (unlicensed) for the treatment of neuropathic pain  

Sep 2015 

Final 

 

pdf document (335 KB)  

Toujeo® Insulin Glargine  

Sep 2015 

Final 

 

pdf document (107 KB)  

Treatments (methylphenidate, atomoxetine, dexamfetamine and lisdexamfetamine) for Adult ADHD  

Oct 2014 

Final 

 

pdf document (184 KB)  

Treclin® (Clindamycin 1% + 0.025% tretinoin) gel for acne vulgaris  

Jul 2014 

Final 

 

pdf document (107 KB)  

Ulipristal Acetate (Ellaone®) for EHC  

Apr 2014 

Final 

 

pdf document (188 KB)  

Umeclidinium (Incruse®Ellipta®) for COPD  

Sep 2014 

Final 

 

pdf document (197 KB)  

Umeclidinium/Vilanterol (Anoro® Ellipta®) Combination Inhaler for COPD  

Sep 2014 

Final 

 

pdf document (230 KB)  

Vit D for Insufficiency & Deficiency  

Mar 2016 

Final 

 

pdf document (241 KB)  

Vitamin D For Deficiency and Insufficiency (paediatrics)  

Apr 2016 

Final 

 

pdf document (105 KB)  

Vitamins, Minerals and Supplements all indications  

Oct 2012 

Final 

 

pdf document (170 KB)  

Xultophy® (Liraglutide +Insulin Degludec) for the treatment of adults with T2DM  

May 2015 

Final 

 

pdf document (69 KB)  

Yohimbine for ED  

Sep 2007 

Final 

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer